Moods Disorders Completed Phase 2 Trials for Neuropeptide Y (DB11788)

Also known as: Mood Disorders / Mood Disorder

IndicationStatusPhase
DBCOND0058256 (Moods Disorders)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00748956Intranasal Administration of Neuropeptide Y in Healthy Male VolunteersBasic Science